Study of APVO436 in Elderly or Unfit Patients With Newly Diagnosed AML

NCT04973618 · clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped Change of strategy

Conditions

Interventions

Sponsor

Aptevo Therapeutics